Literature DB >> 15452863

Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics.

Harry Pantazopoulos1, David Stone, John Walsh, Francine M Benes.   

Abstract

Several lines of evidence have pointed to a role of the dopamine system in the pathophysiology of schizophrenia. A recent postmortem study demonstrated a selective decrease of tyrosine hydroxylase fibers on pyramidal neurons in sector CA2 in the hippocampus of schizophrenics. Although both brain imaging and postmortem studies have examined the distribution of the D1 receptor in the prefrontal and cingulate cortex, no study to date has examined its expression of mRNA using a high-resolution autoradiographic approach. In order to further assess whether the regulation of the dopamine D1 receptor is altered in hippocampal neurons in this disorder, we used in situ hybridization (ISH) to measure the expression of messenger RNA for this receptor in the dentate gyrus and sectors CA1-4. Both the number of cells expressing D1 mRNA and the amount of expression per cell were measured in 15 schizophrenic, 15 bipolar disorder, and 15 normal control subjects. The results show a significant (21%) and selective decrease in D1 mRNA expression in sector CA3 of schizophrenic subjects. First-degree relatives of schizophrenics did not show any differences in either the expression of D1 mRNA per cell or the number of cells expressing this mRNA when compared to a separate group of normal controls matched for age and PMI. Subjects with bipolar disorder also showed a significant (25%) and selective increase of D1 mRNA expression in sector CA2. Other hippocampal sectors did not show significant changes. These findings in schizophrenics and bipolars were also associated with inverse changes in the overall number of neurons expressing D1 mRNA in sectors CA3 and CA2, respectively. This study shows diagnosis-specific changes in D1 mRNA expression in the hippocampus of schizophrenic versus bipolar subjects and suggests that this neuromodulatory system may show distinct changes in the pathophysiology of the two disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452863     DOI: 10.1002/syn.20076

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  12 in total

1.  Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors.

Authors:  Carla Ferrada; Estefanía Moreno; Vicent Casadó; Gerold Bongers; Antoni Cortés; Josefa Mallol; Enric I Canela; Rob Leurs; Sergi Ferré; Carme Lluís; Rafael Franco
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

2.  Fenproporex increases locomotor activity and alters energy metabolism, and mood stabilizers reverse these changes: a proposal for a new animal model of mania.

Authors:  Gislaine T Rezin; Camila B Furlanetto; Giselli Scaini; Samira S Valvassori; Cinara L Gonçalves; Gabriela K Ferreira; Isabela C Jeremias; Wilson R Resende; Mariane R Cardoso; Roger B Varela; João Quevedo; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2013-10-15       Impact factor: 5.590

3.  Overexpression of diacylglycerol kinase η enhances Gαq-coupled G protein-coupled receptor signaling.

Authors:  Joseph E Rittiner; Victoria E Brings; Mark J Zylka
Journal:  Mol Pharmacol       Date:  2014-03-07       Impact factor: 4.436

4.  Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania.

Authors:  Benicio N Frey; Samira S Valvassori; Gislaine Z Réus; Márcio R Martins; Fabrícia C Petronilho; Katrine Bardini; Felipe Dal-Pizzol; Flávio Kapczinski; João Quevedo
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

5.  Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia.

Authors:  Harry Pantazopoulos; Nicholas Lange; Ross J Baldessarini; Sabina Berretta
Journal:  Biol Psychiatry       Date:  2006-09-01       Impact factor: 13.382

Review 6.  Role of oxidative stress in the pathophysiology of bipolar disorder.

Authors:  Amanda V Steckert; Samira S Valvassori; Morgana Moretti; Felipe Dal-Pizzol; João Quevedo
Journal:  Neurochem Res       Date:  2010-05-25       Impact factor: 3.996

7.  Decreased GRK3 but not GRK2 expression in frontal cortex from bipolar disorder patients.

Authors:  Jagadeesh S Rao; Stanley I Rapoport; Hyung-Wook Kim
Journal:  Int J Neuropsychopharmacol       Date:  2009-04-29       Impact factor: 5.176

8.  When the party is over: depressive-like states in rats following termination of cortical D1 receptor overexpression.

Authors:  Nadja Freund; Britta S Thompson; Kai Sonntag; Shirisha Meda; Susan L Andersen
Journal:  Psychopharmacology (Berl)       Date:  2016-01-14       Impact factor: 4.530

Review 9.  Amygdalocortical circuitry in schizophrenia: from circuits to molecules.

Authors:  Francine M Benes
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

Review 10.  Molecular substrates of schizophrenia: homeostatic signaling to connectivity.

Authors:  M A Landek-Salgado; T E Faust; A Sawa
Journal:  Mol Psychiatry       Date:  2015-09-22       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.